InvestorsHub Logo
Followers 72
Posts 6896
Boards Moderated 0
Alias Born 12/07/2011

Re: Here Today post# 213261

Wednesday, 01/17/2018 10:41:30 PM

Wednesday, January 17, 2018 10:41:30 PM

Post# of 403090
Too much. IMO. Way too much.
I love thinking about that, but a phase 3 ready drug would need to be exceptional....like...99.9% prevention rates to garner that.

Valvide was 1 million upfront
100+ in milestones
Double digit royalties that will increase as sales do.

I know we trump that drug, and also are one of the only shows in town for prevention. So I believe ours would be higher.

I’d like to see something like 10 - 15 million upfront 10 million in open market share purchase paid for phase 3 and milestones fore BTD and specific phase 3 read outs. With double digit royalties that can also increase as sales do.

However, I think we have a single suitor for all of B. I think it’s Pfizer - just my hunch.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News